Cargando…
Limiting Damage during Infection: Lessons from Infection Tolerance for Novel Therapeutics
In the field of infectious disease control, novel therapies are focusing on reducing illness caused by pathogens rather than on reducing the pathogen burden itself. Here, Vale and colleagues highlight some potential consequences of such therapeutics for pathogen spread and evolution.
Autores principales: | Vale, Pedro F., Fenton, Andy, Brown, Sam P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897360/ https://www.ncbi.nlm.nih.gov/pubmed/24465177 http://dx.doi.org/10.1371/journal.pbio.1001769 |
Ejemplares similares
-
Alternative therapeutics for self-limiting infections—An indirect approach to the antibiotic resistance challenge
por: Wollein Waldetoft, Kristofer, et al.
Publicado: (2017) -
Commencing open heart surgery in resource limited countries: lessons from the LASUTH experience
por: Oludara, Mobolaji Adewale, et al.
Publicado: (2014) -
Tracing Personalized Health Curves during Infections
por: Schneider, David S.
Publicado: (2011) -
COVID-19 and healthcare lessons already learned
por: Terry, Nicolas
Publicado: (2020) -
Development of Phage Lysins as Novel Therapeutics: A Historical Perspective
por: Fischetti, Vincent A.
Publicado: (2018)